Franklin Resources
IBB icon

Franklin Resources’s iShares Biotechnology ETF IBB Stock Holding History

Franklin Resources’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
14,017
-150
-1% -$25.8K ﹤0.01% 1892
2026
Q1 		$2.39M Hold
14,167
– – ﹤0.01% 1851
2025
Q4 		$2.39M Hold
14,167
– – ﹤0.01% 1706
2025
Q3 		$2.05M Sell
14,167
-55
-0.4% -$7.51K ﹤0.01% 1764
2025
Q2 		$1.8M Sell
14,222
-3,958
-22% -$486K ﹤0.01% 1747
2025
Q1 		$2.33M Sell
18,180
-3
-0% -$407 ﹤0.01% 1632
2024
Q4 		$2.4M Sell
18,183
-102
-0.6% -$14.3K ﹤0.01% 1672
2024
Q3 		$2.66M Buy
18,285
+580
+3% +$83.9K ﹤0.01% 1637
2024
Q2 		$2.43M Sell
17,705
-1,002
-5% -$134K ﹤0.01% 1628
2024
Q1 		$2.57M Sell
18,707
-1,062
-5% -$145K ﹤0.01% 1634
2023
Q4 		$2.69M Sell
19,769
-1,134
-5% -$138K ﹤0.01% 1303
2023
Q3 		$2.56M Sell
20,903
-79
-0.4% -$10K ﹤0.01% 1304
2023
Q2 		$2.66M Buy
20,982
+1,996
+11% +$259K ﹤0.01% 1317
2023
Q1 		$2.45M Sell
18,986
-160
-0.8% -$20.9K ﹤0.01% 1304
2022
Q4 		$2.51M Sell
19,146
-290
-1% -$37.5K ﹤0.01% 1312
2022
Q3 		$2.27M Sell
19,436
-150
-0.8% -$18.6K ﹤0.01% 1299
2022
Q2 		$2.3M Sell
19,586
-440
-2% -$52.2K ﹤0.01% 1313
2022
Q1 		$2.61M Sell
20,026
-336
-2% -$43.8K ﹤0.01% 1337
2021
Q4 		$3.11M Buy
20,362
+262
+1% +$40.6K ﹤0.01% 1371
2021
Q3 		$3.25M Buy
20,100
+2,162
+12% +$364K ﹤0.01% 1319
2021
Q2 		$2.94M Buy
17,938
+1,675
+10% +$258K ﹤0.01% 1263
2021
Q1 		$2.45M Buy
16,263
+522
+3% +$82.9K ﹤0.01% 1289
2020
Q4 		$2.38M Sell
15,741
-650
-4% -$92.9K ﹤0.01% 1251
2020
Q3 		$2.22M Buy
16,391
+5,845
+55% +$793K ﹤0.01% 1191
2020
Q2 		$1.5M Buy
+10,546
New +$1.34M ﹤0.01% 1201
2016
Q1 		– Sell
-1,800
Closed -$203K – 1535
2015
Q4 		$203K Buy
+1,800
New +$195K ﹤0.01% 1538
2015
Q3 		– Sell
-1,800
Closed -$221K – 1599
2015
Q2 		$221K Buy
+1,800
New +$215K ﹤0.01% 1559

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Franklin Resources's IBB Position: Q2 2026 in Review

Franklin Resources reduced its iShares Biotechnology ETF (IBB) stake by 1.1% in Q2 2026, selling an estimated $25.8K and leaving 14,017 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Franklin Resources first reported a position in IBB in Q2 2015 and has held it in 27 quarters since. The position peaked at $3.25M in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Franklin Resources held 14,017 shares of iShares Biotechnology ETF worth $2.67M as of Q2 2026.
  • Franklin Resources sold 150 iShares Biotechnology ETF shares in Q2 2026, an estimated $25.8K.
  • iShares Biotechnology ETF made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1892 holding.
  • Franklin Resources first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 27 quarters since.
  • Franklin Resources's iShares Biotechnology ETF position peaked at $3.25M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.